Illumina (NASDAQ:ILMN) held its 2026 annual meeting of stockholders, with Chief Executive Officer Jacob Thaysen presiding as chairman of the meeting. The company conducted the formal voting portion of the meeting before closing the polls and moving to a brief question-and-answer session, during which no stockholder questions were submitted.
Scott Davies, Illumina’s chief legal officer and secretary, served as inspector of election and reviewed the meeting procedures and preliminary voting results. Davies said the company’s list of registered stockholders showed that 151,906,915 shares of common stock were entitled to vote as of the March 26, 2026, record date. He also said a preliminary count indicated that holders of a majority of the outstanding shares were present in person or by proxy, establishing a quorum.
Stockholders Considered Three Proposals
- The election of nine director nominees to serve until the 2027 annual stockholders meeting.
- The ratification of Ernst & Young as Illumina’s independent registered public accounting firm for the fiscal year ending Jan. 3, 2027.
- An advisory vote approving compensation paid to the company’s named executive officers, as disclosed in the proxy statement.
Davies said preliminary voting returns indicated that each of the director nominees had received sufficient votes for election to the board. The nominees were Scott Gottlieb, Jacob Thaysen, Caroline Dorsa, David King, Anna Richo, Keith Meister, Philip Schiller, Sue Siegel and Scott Ullem. Davies noted that each nominee currently serves on Illumina’s board, except for King.
The company also reported that the proposal to ratify Ernst & Young as its independent registered public accounting firm had received sufficient votes for approval. In addition, the advisory proposal on executive compensation had received sufficient votes for approval, according to the preliminary results.
Final Results Expected in SEC Filing
Davies emphasized that the voting results announced during the meeting were preliminary and subject to the closing of the polls, final review of the vote tabulation and certification. He said the final certified tabulation would be incorporated into the minutes of the meeting.
Illumina said it plans to disclose the final voting results in a Form 8-K filing with the Securities and Exchange Commission within four business days of the meeting.
No Stockholder Questions Submitted
After the formal portion of the meeting was adjourned and the polls were closed, Thaysen opened the webcast for a question-and-answer session. He said the company would spend up to 15 minutes addressing questions and comments related to Illumina’s business and noted that similar questions could be grouped together.
Thaysen also provided a standard caution that any remarks during the discussion could include forward-looking statements and referred stockholders to the company’s SEC filings, including its most recent Forms 10-K and 10-Q, for factors that could cause actual results to differ materially from expectations.
No questions were submitted during the session, and the webcast was concluded.
About Illumina (NASDAQ:ILMN)
Illumina, Inc (NASDAQ: ILMN) is a global life sciences company that develops, manufactures and markets integrated systems for the analysis of genetic variation and function. Headquartered in San Diego, California and founded in 1998, Illumina offers a range of sequencing and array-based technologies used by academic researchers, clinical laboratories, pharmaceutical and biotechnology companies, consumer genomics firms and agricultural researchers to enable discovery, translational research and clinical applications.
The company’s product portfolio includes next-generation sequencing (NGS) platforms and associated consumables, microarrays for genotyping and methylation analysis, library preparation kits and targeted assays.
